- Home
- TVRD vs NCA Comparison
TVRD vs NCA Comparison
Compare TVRD & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- NCA
- Stock Information
- Founded
- TVRD 2017
- NCA 1987
- Country
- TVRD United States
- NCA United States
- Employees
- TVRD N/A
- NCA N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- NCA Investment Managers
- Sector
- TVRD Health Care
- NCA Finance
- Exchange
- TVRD Nasdaq
- NCA Nasdaq
- Market Cap
- TVRD 246.5M
- NCA 280.8M
- IPO Year
- TVRD N/A
- NCA N/A
- Fundamental
- Price
- TVRD $29.92
- NCA $8.53
- Analyst Decision
- TVRD Strong Buy
- NCA
- Analyst Count
- TVRD 5
- NCA 0
- Target Price
- TVRD $59.20
- NCA N/A
- AVG Volume (30 Days)
- TVRD 23.2K
- NCA 59.6K
- Earning Date
- TVRD 08-14-2025
- NCA 01-01-0001
- Dividend Yield
- TVRD N/A
- NCA 3.92%
- EPS Growth
- TVRD N/A
- NCA N/A
- EPS
- TVRD N/A
- NCA N/A
- Revenue
- TVRD N/A
- NCA N/A
- Revenue This Year
- TVRD N/A
- NCA N/A
- Revenue Next Year
- TVRD N/A
- NCA N/A
- P/E Ratio
- TVRD N/A
- NCA N/A
- Revenue Growth
- TVRD N/A
- NCA N/A
- 52 Week Low
- TVRD $8.13
- NCA $7.77
- 52 Week High
- TVRD $34.31
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- TVRD 65.43
- NCA 52.30
- Support Level
- TVRD $22.91
- NCA $8.45
- Resistance Level
- TVRD $31.54
- NCA $8.54
- Average True Range (ATR)
- TVRD 1.65
- NCA 0.07
- MACD
- TVRD 0.61
- NCA -0.00
- Stochastic Oscillator
- TVRD 81.28
- NCA 56.52
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.